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Osf2/Cbfa1: A Transcriptional Activator
of Osteoblast Differentiation
Patricia Ducy,* Rui Zhang,* viewed as the bone-forming cell. Progress in under-
standing osteoblast differentiation has been hamperedValeÂ rie Geoffroy,* Amy L. Ridall,²
and GeÂ rard Karsenty³ by the small number of molecular markers truly specific
to the osteoblast and by the absence of a morphologic*Department of Molecular Genetics
M. D. Anderson Cancer Center feature distinguishing this cell from a fibroblast (Aubin
and Liu, 1996).²Department of Basic Science
Dental Branch It is likely that differentiation along the osteoblast lin-
eage involves osteoblast-specific transcription factorsUniversity of Texas
Houston, Texas 77030 (OSFs) that have yet to be identified. To search for OSFs,
we and others studied the regulation of expression of
Osteocalcin, theonly gene expressed in osteoblasts and
in no other ECM-producing cell type (Towler et al., 1994;Summary
Ducy and Karsenty, 1995). We initially characterized a
cis-acting element, termed OSE2, in the promoter of theThe osteoblast is the bone-forming cell. The molecular
mouse Osteocalcin gene 2 (OG2) that binds a factorbasis of osteoblast-specific gene expression and dif-
present only in osteoblasts nuclear extracts and confersferentiation is unknown. We previously identified an
osteoblast-specific activity on a heterologous promoterosteoblast-specific cis-acting element, termed OSE2,
(Ducy and Karsenty, 1995). Analysis of Osf2, the osteo-in the Osteocalcin promoter. We have now cloned the
blast nuclear activity binding to OSE2, showed that it iscDNA encoding Osf2/Cbfa1, the protein that binds to
immunologically related to the Cbfa transcription factorsOSE2. Osf2/Cbfa1 expression is initiated in the mesen-
(Geoffroy et al., 1995; Merriman et al., 1995). The Cbfachymal condensations of the developing skeleton, is
proteins are the mouse homologs of Runt, a Drosophilastrictly restricted to cells of the osteoblast lineage
pair-rule gene product (Gergen and Wieschaus, 1985).thereafter, and is regulated by BMP7 and vitamin D3.
Runt and the Cbfa proteins have a high degree of homol-Osf2/Cbfa1 binds to and regulates the expression
ogy in their DNA-binding domain, a 128 amino acid-longof multiple genes expressed in osteoblasts. Finally,
motif called the runt domain (Kagoshima et al., 1993).forced expression of Osf2/Cbfa1 in nonosteoblastic
The mouse genome contains three known runt homo-cells induces the expression of the principal osteo-
logs encoding numerous isoforms with well-character-blast-specific genes. This study identifies Osf2/Cbfa1
ized expression patterns (Bae et al., 1992; Ogawa et al.,as an osteoblast-specific transcription factor and as
1993; Wijmenga et al., 1995; Simeone et al., 1995). Nonea regulator of osteoblast differentiation.
of the described Cbfa transcripts has been shown to be
expressed predominantly in bone, suggesting that a still
unknown member(s) of the Cbfa family controls osteo-Introduction
blast-specific expression of Osteocalcin.
In this paper, we report the cloning of Osf2/Cbfa1, theSkeletal development is a multistep process. It includes
factor that binds to the OSE2 element. Osf2/Cbfa1 haspatterning of skeletal elements, commitment of mesen-
several functional features that identify it as a transcrip-chymal cells to chondrogenic and osteogenic lineages,
tional regulator of osteoblast differentiation.and terminal differentiation of precursor cells into three
specialized cell types: the chondrocyte in cartilage and
the osteoblast and osteoclast in bone. Many genes en- Results
coding either growth factors or transcription factors
were shown through genetic studies to control skeleton Isolation and Expression of Osf2/Cbfa1
patterning (for review, see Cohn and Tickle, 1996; Ho- To search for a Cbfa-related mRNA in osteoblasts, we
gan, 1996). These genetic analyses also showed that performed Northern blot analysis using poly(A)1 RNA
mutations in these genes do not severely affect the dif- from mouse thymus and spleen, two tissues expressing
ferentiation of the skeleton-specific cell types, sug- the known Cbfas, and from primary osteoblasts. Hybrid-
gesting that patterning and cell differentiation in the ization with a probe containing sequences coding for the
skeleton are achieved through different genetic path- runt domain of Cbfa1, a gene thought to be expressed in
ways. Consistent with this hypothesis, genes such as T lymphocytes (Satake et al., 1995), detected a transcript
PTHrP and c-fos were shown to control chondrocyte in osteoblasts that was at least 20-fold more abundant
and osteoclast differentiation, respectively, without af- than the signal detected in thymus (Figure 1A). Thus,
fecting skeletal patterning (Johnson et al., 1992; Wang we screened at reduced stringency a mouse osteoblast
et al., 1992; Karaplis et al., 1994). cDNA library using this probe.Three independent clones
The osteoblast is a cell of mesenchymal origin that, encoding the same protein were identified. This cDNA
once terminally differentiated, produces most of the pro- was called Osf2/Cbfa1 because it encodes the factor
teins present in the bone extracellular matrix (ECM) and binding to OSE2 and is encoded by the Cbfa1 gene (see
controls the mineralization of this ECM. As such, it is below).
Osf2/Cbfa1 contains a glutamine/alanine-rich domain
at its N-terminal end, a runt domain, and a proline/serine/³To whom correspondence should be addressed.
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Figure 1. Cloning and Expression of the
Mouse Osf2/Cbfa1 cDNA
(A) Poly(A)1 RNA isolated from mouse primary
osteoblasts (lane 1), spleen (lane 2), and thy-
mus (lanes 3 and 4) were analyzed by North-
ern blot, using a fragment of Cbfa1 cDNA
encoding the runt domain as a probe. Equiva-
lent amounts of intactmRNA were run in lanes
1±3 as indicated by hybridization to a b-actin
probe. Lane 4 represents a 20-fold-longer ex-
posure of lane 3.
(B) Amino acid sequence of Osf2/Cbfa1. The
initiation codons are shown in boldface type,
and the runt domain is underlined.
(C) Expression of Osf2/Cbfa1 in tissues of
adult mice. Total RNA (15 mg per lane) was
isolated from adult mouse tissues and ana-
lyzed by Northern blot using an Osf2/Cbfa1-
specific probe. The blot was reprobed with
an 18S rRNA cDNA probe to account for RNA
loading and transfer efficiency.
(D) Differentiation of C3H10T1/2 fibroblasts
cultured in presence of BMP7 (200 ng/ml).
Note the appearance of Osf2/Cbfa1 tran-
scripts before Osteocalcin transcripts.
(E) Regulation of Osf2/Cbfa1 expression by
1,25(OH)2D3. Mouse primary osteoblasts were
cultured in the presence or absence of 1028
M 1,25(OH)2D3 for 12 hr before RNAs were
prepared for Northern analysis.
threonine-rich (PST)domain at its C-terminal end (Figure abolishing binding of osteoblast nuclear extracts to
OSE2 (Zhang et al., 1997). Consistent with this ob-1B). The sequencescoding for the runt and PST domains
are identical in Osf2/Cbfa1 and the originally described servation, treatment of primary mouse osteoblasts with
1,25(OH)2D3 abolished Osf2/Cbfa1 expression (Fig-Cbfa1; however, these two transcripts differ totally in
their 59 end. Osf2/Cbfa1 encodes a different amino acid ure 1E).
stretch 59 of the glutamine/alanine domain and has a
different 59 untranslated sequence (data not shown). The Osf2/Cbfa1 Increases Osteocalcin Promoter
Activity Through Its Binding to OSE2sequence identity in their 39 end and the existence of
exons coding for Osf2/Cbfa1 59 sequence in the Cbfa1 The DNA-binding ability of Osf2/Cbfa1 was analyzed
using a histidine-tagged recombinant Osf2/Cbfa1 pro-gene suggest that Osf2/Cbfa1 originates from the Cbfa1
gene (data not shown). tein (His-Osf2/Cbfa1) in electrophoretic mobility-shift
assay (EMSA). Several mutated OSE2 elements wereWe performed Northern blot analysis to determine
Osf2/Cbfa1 expression in adult mice. Osf2/Cbfa1 tran- compared with the wild-type OSE2 element for their
ability to bind His-Osf2/Cbfa1 (Figure 2A). Any pointscripts were detectable only in bone and osteoblasts
but in no other tissues examined. In particular, no Osf2/ mutation within the 59-AACCAC-39 sequence abolished
binding of His-Osf2/Cbfa1, while a mutation located out-Cbfa1 expression was detected in thymus and spleen,
two organs where the other Cbfas are expressed, or in side this core sequence did not affect His-Osf2/Cbfa1
binding to DNA. An anti-CBFA antiserum that abolishestissues containing fibroblasts (skin), myoblasts (muscle,
heart), or chondrocytes (cartilage), three other cell types binding of nuclear extracts to OSE2 (Geoffroy et al.,
1995) also abolished binding of His-Osf2/Cbfa1 toOSE2,of mesenchymal origin (Figure 1C).
Osf2/Cbfa1 regulation of expression by molecules af- demonstrating that Osf2/Cbfa1 and the binding activity
present in osteoblast nuclear extracts are relatedfecting osteoblast differentiation was examined next.
The C3H10T1/2 fibroblasts do not normally express any (Figure 2B).
Osf2/Cbfa1 transcriptional activity was assessed byosteoblast-specific genes. However, treatment of these
cells with BMP2 and BMP7 can induce osteoblast DNA cotransfection experiments in F9 mouse teratocar-
cinoma cells, which do not express either Osteocalcindifferentiation (Piccolo et al., 1996). BMP7 treatment
of C3H10T1/2 cells induced Osf2/Cbfa1 expression or the Cbfa genes (Furukawa et al., 1990; Ducy and
Karsenty, 1995). The activity of a construct containingbefore the expression of any osteoblast-specific gene
(Figure 1D). 1,25(OH)2D3, a hormone regulating bone six copies of OSE2 oligonucleotides cloned upstream
of the Osteocalcin basal promoter (p6OSE2-luc) wasremodeling, inhibits mouse Osteocalcin expression by
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days post coitum (dpc) embryos,whereas the first ossifi-
cation center cannot be observed before 14.5 dpc (Kauf-
man, 1992).
The first important step during skeletal development
is the formation of mesenchymal cell condensations.
These mesenchymal condensations, identifiable at 12.5
dpc in mouse embryos, form the anlagen or models of
the future skeleton. At that stage, Osf2/Cbfa1 transcripts
mark exclusively thedeveloping skeleton and were pres-
ent in mesenchymal cells of every anlagen (Figure 3B).
These cells also express type II collagen (data not
shown), suggesting that they have the ability to differen-
tiate along the osteoblast or the chondrocyte lineage.
In 12.5 dpc mouse embryos, the only chondrocytes to
be fully differentiated reside in the Meckel's cartilage
(Kaufman, 1992). These cells expressed a1(II) collagen, a
marker of the chondrocytes, butnot Osf2/Cbfa1 (Figures
3B and 3C).
We also performed in situ hybridization on 16.0 dpc
embryos. At this stage, ossification centers are now
present in most of the skeleton, but not all bones are
mineralized, as assessed by alizarin red staining of skel-
Figure 2. DNA Binding and Transcription Ability of Osf2/Cbfa1 etal preparations (Kaufman, 1992). In the skull of 16.0
DNA binding was analyzed by EMSA. DNA±protein complexes were dpc embryos, the nasal, frontal, basosphenoid, and ba-
resolved from free DNA on a 5% polyacrylamide gel and visualized sooccipital bones and the mandibles expressed high
by autoradiography. levels of Osf2/Cbfa1 mRNA. Osf2/Cbfa1 expression was
(A) His-Osf2/Cbfa1 was incubated with 32P-labeled wild type (lane
detected in elements such as the manubrium sterni, the1) or mutated OSE2 (lanes 2±8) oligonucleotides. The mutated OSE2
sternebrae, and the hyoid bone (Figure 3D) 12±24 hroligonucleotides are presented in Table 1. The asterisk marks the
before mineralization of these structures.No Osf2/Cbfa1mutation used for subsequent DNA cotransfection experiments
(C±E). expression was detectable in the chondrocytes of the
(B) Abolition of His-Osf2/Cbfa1 binding to OSE2 by an anti-Cbfas Meckel's cartilage or of the manubrium sterni, in the
antiserum. A preimmune serum (lane 2) or antiserum (lane 3) to a fibroblasts of the skin, or in any soft tissues examined
peptide sequence present in Osf2/Cbfa1 was included in the binding
(Figure 3D). In the axial skeleton, Osf2/Cbfa1 expressionreaction.
was restricted to cells of the ossification centers of cau-(C±E) Transcriptional activity of Osf2/Cbfa1 in F9 teratocarcinoma
dal vertebrae two days before they become mineralizedcells (C) and in C3H10T1/2 fibroblastic cells (D). (E) Activation of the
147 bp OG2 promoter by Osf2/Cbfa1 in C3H10T1/2 cells. Cells were (Figure 3E). The expression of Matrix gla protein (Mgp),
cotransfected with luciferase-fusion constructs as reporter plas- a gene expressed in chondrocytes butnot inosteoblasts
mids, pCMV (open bars) or pCMV-Osf2/Cbfa1 (closed bars) as ef- (Luo et al., 1997), was mutually exclusive with Osf2/
fector plasmids, and pSVb-gal plasmid as an internal control of
Cbfa1 expression (Figure 3F) in caudal vertebrae, indi-transfection efficiency. Data are presented as fold activation relative
cating again that Osf2/Cbfa1 expression is absent fromto the activity obtained with the pCMV effector plasmid. Values
differentiated chondrocytes.represent average of luciferase to b-galactosidase ratios obtained
from four independent transfection experiments, with error bars In summary, Osf2/Cbfa1 expression occurs early dur-
representing the standard deviation of the mean. ing skeletal development and is restricted to cells of
the mesenchymal condensations and of the osteoblast
lineage. It is detectable in all bones examined, regard-
less of their embryologic origin and their mechanismsstimulated more than 70-fold upon cotransfection with
of ossification (intramembranous or endochondral), sug-the Osf2/Cbfa1 expression vector. This effect was abol-
gesting that it may regulate the expression of multipleished by a 2 bp mutation in OSE2 that abolishes binding
genes in developing osteoblasts.of His-Osf2/Cbfa1 (p6OSE2m-luc) (Figure 2C). Similar
results were obtained when the DNA cotransfections
were performed in C3H10T1/2 fibroblasts (Figure 2D).
Osf2/Cbfa1 Affects the Expression of SeveralOsf2/Cbfa1 could also transactivate an Osteocalcin pro-
Genes Expressed in Osteoblastsmoter fragment (2147/113) containing a single wild-
OSE2-like elements are present in the promoter of genestype OSE2 element (p147-Luc) (Figure 2E).
such as Osteocalcin gene 1 (OG1), a1(I) collagen, Bsp,
and Osteopontin. The ability of these various OSE2 ele-
ments to bind Osf2/Cbfa1 was examined by EMSA. InOsf2/Cbfa1 Expression Marks Cells of the
Osteoblast Lineage during Development each case, when using osteoblast nuclear extracts, we
observed the generation of a protein±DNA complex thatRT±PCR analysis followed by Southern hybridization us-
ing RNAs from mouse embryos of different stages was was competed away by a wild-type OSE2 oligonucleo-
tide but not by a mutant OSE2 oligonucleotide (Figureperformed to determine when Osf2/Cbfa1 expression is
initiated during mouse development (Figure3A). Surpris- 4A). Likewise, His-Osf2/Cbfa1 bound to labeled oligonu-
cleotides containing the OSE2 sequences present iningly, Osf2/Cbfa1 expression reached a peak in 12.5
Cell
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Figure 3. Osf2/Cbfa1 Expression during Mouse Development
(A) RT±PCR analysis of Osf2/Cbfa1 expression during development. An aliquot of RT±PCR products obtained from 9.5- to 17.5-day-old
embryos were electrophoresed and hybridized with an Osf2/Cbfa1-specific probe. Amplification of Hprt exon 2 was used as an internal control
in each reaction. dpc, days post coitum.
(B±F) Section in situ hybridization using antisense 35S-labeled Osf2/Cbfa1 (B, D, E, and F), a1(II) collagen (C), and Mgp (F) riboprobes. (B)
Osf2/Cbfa1 expression in 12.5 dpc mouse embryo. Mesenchymal condensations of the developing skull (1, 2), ribs (3), vertebrae (4), forelimb
(5), and hindlimb (6) express Osf2/Cbfa1, whereas the chondrocytes of the Meckel's cartilage do not (arrow). (C) a1(II) collagen expression in
the differentiated chondrocytes of the Meckel's cartilage (arrow) of 12.5 dpc embryo. (D) Osf2/Cbfa1 expression in a 16.0 dpc mouse embryo.
Osf2/Cbfa1 mRNA is detected in every bone examined but absent from other tissues. (E and F) Osf2/Cbfa1 (E) and Mgp (F) expression in the
caudal vertebrae of 16.0 dpc mouse embryos. Osf2/Cbfa1 is expressed in the ossification centers of the vertebrae but not in the surrounding
chondrocytes or the fibroblasts of the skin. b, brain; bo, basioccipital bone; bs, basisphenoid bone; c, chondrocytes; f, frontal bone; fb,
forebrain; h, hyoid bone; l, liver; lm, lower mandible; m, ossification within palatal shelf of maxilla; M, Meckel's cartilage; ms, manubrium sterni;
n, nasal bone; oc, ossification center of the vertebral body; pm, premaxilla; rg, root ganglions; s, sternebrae; t, tongue; tr, trachea.
OG1, a1(I) collagen, Bsp, and Osteopontin promoters Cbfa1 in these cells led to Bsp, Osteocalcin, and a1(I)
collagen expression, whereas transfection of the empty(Figure 4B).
The functional relevance of these OSE2 elements was vector did not have this effect (Figure 4E). The C3H10T1/2
cells are pluripotent fibroblasts that are not committedtested by DNA cotransfection and by antisense experi-
ments. In DNA cotransfections, the activity of a mouse to the osteoblast lineage. Transient transfection of
C3H10T1/2 cells with Osf2/Cbfa1 expression vector, butOsteopontin promoter fragment that includes the OSE2
sequence was increased 4-fold upon cotransfection not with the empty vector, led to the induction of Bsp
and Osteocalcin expression (Figure 4F). Finally, tran-with Osf2/Cbfa1 expression vector, while a deletion of
this element abolished this effect (Figure 4C). Osf2/ sient transfection of Osf2/Cbfa1 expression vector in-
duced expression of Osteocalcin and Bsp in mouse skinCbfa1 antisense oligonucleotides were transfected in
ROS17/2.8 osteoblastic cells, and RNA harvested 40 hr fibroblasts (Figure 4G).
later. The Osf2/Cbfa1 antisense oligonucleotide, but not
the control oligonucleotide, led to an abolition of a1(I) Discussion
collagen expression and a marked reduction of expres-
sion of Osteocalcin and Osteopontin (Figure 4D). Osf2/Cbfa1, a Product of the Cbfa1 Gene
Genes controlling cell-specific differentiation in the skel-The results presented above raised the hypothesis
that Osf2/Cbfa1 could induce osteoblast differentiation eton have begun to be identified. To date, these studies
have shed light primarily on chondrocyte and osteoclastof nonosteoblastic cells. To test it, we performed DNA
transfections of cells that normally express neither Osf2/ differentiation. To understand the mechanisms of osteo-
blast differentiation, we studied the regulation of expres-Cbfa1 nor genes characteristic of the osteoblast pheno-
type. The MC3T3-E1 calvarial cells are committed to the sion of Osteocalcin, the most osteoblast-specific gene
and report here the cloning of Osf2/Cbfa1, an osteo-osteoblast lineage but do not express any osteoblast-
specific genes under normal culture conditions (Aubin blast-specific transcription factor that has many fea-
tures of a determinant of osteoblast differentiation.and Liu, 1996). Northern blot analyses of MC3T3-E1cells
transiently transfected with Osf2/Cbfa1cDNA or with the Several arguments indicate that Osf2/Cbfa1 is en-
coded by the Cbfa1 gene, one of the three known mouseempty vector showed that forced expression of Osf2/
Genetic Control of Osteoblast Differentiation
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Figure 4. Osf2/Cbfa1 Controls the Expres-
sion of Several Osteoblast-Specific Genes
(A and B) DNA-binding studies. Labeled dou-
ble-stranded oligonucleotides correspond-
ing to the OSE2 elements present in the pro-
moters of OG1, a1(I)collagen, Bsp, and
Osteopontin (OPN) (see Table 1) were used
in EMSA. (A) EMSA was performed using os-
teoblast nuclear extracts as a source of pro-
teins. Labeled probes were as indicated. (B)
DNA binding performed with His-Osf2/Cbfa1.
Labeled probes were as indicated.
(C) Activation of the Osteopontin promoter
fragment containing an OSE2 sequence by
Osf2/Cbfa1. F9 cells were cotransfected with
p910-Opn-luc that contains the OSE2 ele-
ment orwith p106-Opn-luc that does not con-
tain the OSE2 element, along with pCMV or
pCMV-Osf2/Cbfa1.
(D) Effect of Osf2/Cbfa1 antisense oligonu-
cleotide on osteoblast-specific gene expres-
sion. ROS17/2.8 osteoblastic cells were
transfected with antisense (AS) or control-
scrambled (CS) oligonucleotide. RNAs were
prepared after 40 hr and analyzed for the ex-
pression of a1(I)collagen, Osteocalcin, and
Osteopontin.
(E±G) Induction of osteoblastic markers in
nonosteoblastic cells by Osf2/Cbfa1. Total
RNA (15 mg) from MC3T3-E1 calvaria cells (E),
C3H10T1/2 fibroblastic cells (F), or mouse
skin fibroblasts (G) were collected 40 hr after transient transfection with pCMV (2) or pCMV-Osf2/Cbfa1 (1). Northern blot analysis was
performed using probes for a1(I)collagen, Bsp, Osteocalcin, and Osteopontin transcripts. Blots were reprobed with an 18S rRNA cDNA probe
to account for RNA loading and transfer efficiency.
homologs of the Drosophila runt gene (Ogawa et al., expression was restricted to the subset of cells that will
become osteoblasts butwas not detectable in differenti-1993). First, analysis of the genomic structure of Cbfa1
showed exons encoding Osf2 59 end separated from ated chondrocytes. No other cell types in developing
mouse embryos expressed Osf2/Cbfa1 to a detectablethe exon encoding the glutamine/alanine domain by a
large intron (data not shown). Second, genetic evidence level.
The BMPs are secreted molecules that can induce thein human and mouse demonstrates the role of Cbfa1 in
osteoblast differentiation in the absence of any other cascade of events leading to osteoblast differentiation
(Kingsley, 1994). Here, we show that BMP7 inducedabnormality (Mundlos et al., 1997 [this issue of Cell];
Otto et al., 1997 [this issue of Cell]). Third, in RT±PCR Osf2/Cbfa1 expression in cells where it is not normally
expressed, prior to the expression of any other osteo-experiments we could only amplify sequences corre-
sponding to the 59 end of Osf2/Cbfa1. blast marker genes. This suggests that Osf2/ Cbfa1 is
part of the BMP signaling cascade in osteoblasts.
The down-regulation of Osf2/Cbfa1 expression byOsf2/Cbfa1 Expression and Regulation
Our in situ hybridization experiments show that Osf2/ 1,25(OH)2D3 reported here is in agreementwith a growing
body of clinical evidence suggesting that 1,25(OH)2D3Cbfa1 expression identifies in the mouse embryo a cell
population with dual potentiality: osteoblastic and chon- may prevent osteoblast terminal differentiation and
causes aplastic bone disease (Goodman et al., 1994).droblastic. Indeed, we could already observe its expres-
sion in mesenchymal condensations of the developing
skull, axial, and appendicular skeleton in 12.5 dpc em- Osf2/Cbfa1 Function during
Osteoblast Differentiationbryos. Importantly, at that stage of skeletal develop-
ment, the cells present in these mesenchymal conden- The pattern of expression and regulation of Osf2/Cbfa1
suggest that it may play a much broader role in osteo-sations express many genes thought to be specific to
the chondrocyte phenotype (Horton, 1993). The expres- blast-specific gene expression and differentiation. In-
deed, we identified Osf2/Cbfa1 binding sites in the pro-sion of Osf2/Cbfa1 in these cells at 12.5 dpc indicates
that they have the potential to become osteoblasts and moter of four genes expressed only (the Osteocalcin
genes) or highly (a1(I) collagen, Bsp, and Osteopontin)implies that Osf2/Cbfa1 expression identifies a common
progenitor for the osteoblast and the chondrocyte in the in osteoblasts. Each of these elements was able to bind
Osf2/Cbfa1. The functional relevance of these Osf2/mesenchymal condensations. However, Osf2/Cbfa1 will
remain ªonº only in cells of the osteoblastic lineage later Cbfa1 binding sites is supported by three lines of evi-
dence. First, in DNA cotransfection experiments Osf2/during development. Consistent with this model in 14.5
dpc embryos (data not shown) and in 16.0 dpc embryos, Cbfa1 increased the activity of a fragment of the Osteo-
pontin promoter or the Osteocalcin promoter containingwhen cell differentiation is more advanced, Osf2/Cbfa1
Cell
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a single OSE2 element. Second, antisense experiments Table 1. DNA Sequences Used in EMSA
showed a dramatic decrease in the level of a1(I) colla-
Osteocalcin OSE2 59-AGCTGCAATCACCAACCACAGCA-39
gen, Osteocalcin, and Osteopontin expression in an os- mutant 1 59-AGCTGCACGATCCAACCACAGCA-39
teoblastic cell line. Third, forced expression of Osf2/ mutant 2 59-AGCTGCAATCACGTACCACAGCA-39
Cbfa1 induces osteoblast-specific gene expression in mutant 3 59-AGCTGCAATCACCGGCCACAGCA-39
mutant 4 59-AGCTGCAATCACCAGACACAGCA-39nonosteoblastic cells in vitro. This ability of Osf2/Cbfa1
mutant 5 59-AGCTGCAATCACCAGCCACAGCA-39to induce osteoblast-specific gene expression in nonos-
mutant 6 59-AGCTGCAATCACCAAACACAGCA-39teoblastic cells indicates that Osf2/Cbfa1 is required
mutant 7 59-AGCTGCAATCACCAACCAGAGCA-39
for the differentiation of mesenchymal cells along the OG1 OSE2 59-CGCCGCAATCACCTACCACAGCA-39
osteoblast lineage in vivo. In agreement with our cell- a1 (I) collagen OSE2 59-CCCTTCCCACACCACCCACACAG-39
culture experiments, Cbfa1-deficient mice lack osteo- Bsp OSE2 59-AAATTTAGACTCCAACCTCAGCA-39
Osteopontin OSE2 59-CGCTCTTTGTGCAAACCACACAG-39blasts (Otto et al., 1997).
The OSE2 core binding site is underlined. The mutations are in bold.
Osf2/Cbfa1 and Skeletal Diseases
For a transcription factor like Osf2/Cbfa1 to be responsi-
ble for a genetic disease, one would predict that it will
of oligo(dT) and random oligonucleotides. The cDNA library wasbe a generalized defect involving intramembranous and
built in lgt11 bacteriophage. Plaque screening was performed at
endochondral bone formation. Cbfa1 maps at the same low stringency using as probe the Asp718/HindIII fragment (11431/
location as the gene responsible for cleidocranial dys- 11687) encoding part of Cbfa1 runt domain.
plasia in humans (Mundlos et al., 1995) and in mice (Ccd
DNA-Binding Assaysmouse mutant) (Sillence et al., 1987; Otto et al., 1997),
An AcyI/XbaI (1311/13334) fragment of the Osf2/Cbfa1 cDNA en-and molecular analysis detected nonsense mutations of
coding the full-length protein was ligated in frame with coding se-the CBFA1 gene in patients with cleidocranial dysplasia
quence for the 6 histidine residues in the pTrcHisA vector (In-
(Mundlos et al., 1997). Furthermore, strong genetic evi- vitrogen). His-tagged Osf2/Cbfa1 protein (His-Osf2/Cbfa1) was
dence indicates that Cbfa1 is deleted in the Ccd mouse, enriched on Ni-bound iminodiacetic acid agarose resin (Quiagen)
demonstrating the importance of this gene in osteoblast according the manufacturer's instructions. For EMSA, labeled dou-
ble-stranded oligonucleotides were prepared as previously de-differentiation in vivo (Otto et al., 1997). Osf2/Cbfa1 be-
scribed (Ducy and Karsenty, 1995). The oligonucleotides used inlongs to a family of transcription factors involved in
this study are presented in Table 1. EMSAs were performed asoncogenic transformation, for which rearrangements
previously described (Ducy and Karsenty, 1995) using a bindinghave been shown to cause leukemia (Speck and Tracy, buffer containing 20 mM Tris±HCl (pH 8), 10 mM NaCl, 3 mM EGTA,
1995; Okuda et al., 1996). Thus, it will be important to 0.05% Nonidet P-40, 5 mM dithiothreitol, and 2 mg Poly(dI.dC).
search for rearrangements of the CBFA1 gene in osteo- poly(dI.dC).
sarcoma, the most frequent malignant bone tumor.
RNA Analysis
Total RNA was isolated using the guanidinium thiocyanate-CsClConclusion
gradient method (Sambrook et al., 1989) or RNAzOL (Biotex Lab).Our understanding of the transcriptional control of skel-
Poly(A)1 RNA was isolated using an Oligotex mRNA midi kit (Quia-
etal cell differentiation is at an early stage, compared gen) following the manufacturer's instructions. Analysis of RNA ex-
to other cell types of mesenchymal origin such as the pression was performed by Northern blot as previously described
myoblast (Molkentin and Olson, 1996) or the adipocyte (Sambrook et al., 1989). Probes used include the first 336 bp of
Osf2/Cbfa1 untranslated and coding sequences, the runt domain(Spiegelman and Flier, 1996). Osf2/Cbfa1 identifies a
of Cbfa1, the mouse Osteocalcin cDNA, the mouse Osteopontintranscriptional mechanism that, along the BMP path-
cDNA, the mouse BSP cDNA, the 39 untranslated region of theway, controls osteogenesis. Genetic evidence in hu-
mouse a1(I) collagen cDNA and an 18S rRNA cDNA.mans and mice confirms this hypothesis and demon-
For RT±PCR analysis, DNAse I-treated total RNA was reverse
strates the essential function of Osf2/Cbfa1 during bone transcribed using oligo(dT). cDNAs were amplified using the primers
development in vivo. These findings do not exclude, 59-GAGGGCACAAGTTCTATCTGGA-39 and 59-GGTGGTCCGCGAT
GATCTC-39. PCR products were separated on agarose gel, trans-however, that besides Osf2/Cbfa1other OSFs mayexist.
ferred to Hybond-N1 (Amersham), and hybridized with a 32P probeIndeed, OSE1, another cis-acting element in the OG2
encompassing the first 336 bp of Osf2/Cbfa1. Amplification of exonpromoter, binds a different OSF (Ducy and Karsenty,
2 of the Hprt gene was used as a control for cDNA quality and1995), and another sequence controlling osteoblast-
loading.
specific expression of the a1(I) collagen genes has re-
cently been identified (Bogdanovic et al., 1995; Rossert In Situ Hybridization
et al., 1996). It is possible that several nuclear factors The 336 bp 59 fragment of Osf2/Cbfa1 cDNA, the mouse MGP cDNA
(Luo et al., 1997), and the 39 untranslated region of the mouse a1(II)act together in a combinatorial fashion to achieve osteo-
collagen cDNAs were used to generate antisense riboprobes. Sec-blast differentiation (Kuo et al., 1992; Molkentin and
tions of 8 mm were mounted onto polylysine-treated slides. Hybrid-Olson, 1996; Spiegelman and Flier, 1996). The relative
ization was overnight at 508C, and washes were at 628C. Autoradiog-
importance of Osf2/Cbfa1 and other factors during os- raphy, Hoechst 33258 staining, and photography were performed
teoblast differentiation will be elucidated when cDNAs as described (Sundin et al., 1990).
for these factors become available.
Cell Culture, DNA Transfections, and Osteoblast Differentiation
Mouse F9 teratocarcinoma cells, C3H10T1/2 fibroblasts, MC3T3-Experimental Procedures
E1 calvaria cells, and rat osteosarcoma ROS17/2.8 cells were main-
tained as previously described (Ducy and Karsenty, 1995; Zhang etCloning the Osf2/Cbfa1 cDNA
al., 1997). Mouse skin fibroblasts were isolated by collagenase/cDNA was prepared using poly(A)1 RNA from mouse primary osteo-
blast cultures (Ducy and Karsenty, 1995) and, as a primer, a mixture trypsin (0.1 mg/ml/2.5%) digestion and maintained in aMEM/10%
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FBS. For induction of osteoblast differentiation, C3H10T1/2 were Goodman, W.G., Ramirez, J.A., Belin, T.R., Chon, Y., Gales, B., Se-
gre, G., and Salusky, I.B. (1994). Development of adynamic boneplated at a density of 2 3 104 cells/cm2. After 24 hr (t0), this medium
was replaced by fresh mixture complemented with 200 ng/ml of in patients with secondary hyperparathyroidism after intermittent
calcitriol therapy. Kidney Int. 46, 1160±1166.BMP7 or with vehicle and changed every 2 days. Primary mouse
calvarial osteoblasts were cultured and treated with 1,25(OH)2D3 Hogan, B.L.M. (1996). Bone morphogenetic proteins: multifunctional
(1028 M) or vehicle for 12 hr, as described (Zhang et al., 1997). regulators of vertebrate development. Genes Dev. 10, 1580±1594.
The expression plasmid for Osf2/Cbfa1 (pCMV-Osf2/Cbfa1) was Horton, W.A. (1993). Morphology of connective tissue: cartilage. In
constructed by inserting Osf2/Cbfa1 cDNA under transcriptional Connective Tissue and Its Heritable Disorders (Chichester, UK: Wi-
control of the CMV promoter region of the pCMV5 plasmid (Eastman ley-Liss, Inc), pp. 73±84.
Kodak Co). p910-Opn-luc was obtained by cloning of the 2910/190
Johnson, R.S., Spiegelman, B.M., and Papaioannou, V. (1992). Pleio-PstI fragment of the mouse Osteopontin promoter into pGL2 vector
tropic effects of a null mutation in the c-fos proto-oncogene. Cell(Promega). p106-Opn-luc was subsequently generated by deletion
71, 577±586.of the 2910/2106 fragment. Cells were cotransfected with each
Kagoshima, H., Shigesada, K., Satake, M., Ito, Y., Miyoshi, H., Ohki,reporter plasmid (5 mg), 5 mg of expression plasmid, and 2 mg of
M., Pepling, M., and Gergen, P. (1993). The Runt domain identifiespSVb-gal using the calcium phosphate coprecipitation procedure
a newfamily of heteromeric transcriptional regulators. Trends Genet.(Sambrook et al., 1989). After transfections, b-galactosidase and
9, 338±341.luciferase activities were measured as previously described (Zhang
et al., 1997). DNA cotransfections were performed in duplicates Karaplis, A.C., Luz, A., Glowacki, J., Bronson, R.T., Tybulewicz,
and repeated at least four times. For overexpression experiments, V.L.J., Kronenberg, H.M., and Mulligan, R.C. (1994). Lethal skeletal
expression plasmids were transfected for 4 hr with Lipofectamin dysplasia from targeted disruption of the parathyroid hormone-
(GIBCO) following the manufacturer's instructions. Antisense (59-CTG related peptide gene. Genes Dev. 8, 277±289.
CGCTGAAGAGGCTGTTTGA-39) or control-scrambled (59-CGCGTA Kaufman, M.H., ed. (1992). The Atlas of Mouse Development (San
TCGTGATGTAGACGTG-39) oligonucleotides (0.1 mM) synthetized Diego, California: Academic Press), pp. 389±407.
in the phosphothioate-modified condition (Midlands, Inc) were
Kingsley, D.M. (1994). The TGF-b superfamily; new members, newtransfected for 5 hr using Lipofectamin (GIBCO). RNAs were isolated
receptors and new genetic tests of function in different organisms.40 hr after transfection.
Genes Dev. 8, 133±146.
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